Clostridium difficile-associated diarrhea in a tertiary care medical center.

about

Analysis of risk factors and clinical manifestations associated with Clostridium difficile disease in Serbian hospitalized patients.

P2860

Q37314288-ED11A425-7354-4CB2-BA1C-B0AA3F84669D

P2860

Clostridium difficile-associated diarrhea in a tertiary care medical center.

Item

http://www.wikidata.org/entity/Q42423715

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Clostridium difficile-associated diarrhea in a tertiary care medical center.

@en

Clostridium difficile-associated diarrhea in a tertiary care medical center.

@nl

type

Item

label

Clostridium difficile-associated diarrhea in a tertiary care medical center.

@en

Clostridium difficile-associated diarrhea in a tertiary care medical center.

@nl

prefLabel

Clostridium difficile-associated diarrhea in a tertiary care medical center.

@en

Clostridium difficile-associated diarrhea in a tertiary care medical center.

@nl

P1476

Clostridium difficile-associated diarrhea in a tertiary care medical center

@en

P2093

David N Scheck

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Stroup

http://www.w3.org/2001/XMLSchema#string

Marilee D Obritsch

http://www.w3.org/2001/XMLSchema#string

Ryan M Carnahan

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients.

Moxifloxacin-induced Clostridium difficile-associated diarrhea.

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Fluoroquinolone use and Clostridium difficile-associated diarrhea.

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence.

Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients.

Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?

Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

P304

363-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08998280.2010.11928654

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20944758

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

Afọ ọsịsa

P932

2943450

http://www.w3.org/2001/XMLSchema#string

Clostridium difficile-associated diarrhea in a tertiary care medical center.

about

P2860

P2860

Clostridium difficile-associated diarrhea in a tertiary care medical center.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932